|
Category 产品分类 |
Product Name 产品名称 |
Code 代码 |
CAS No. |
Registration number 登记号 |
|---|---|---|---|---|
|
Taxane 紫杉烷类 |
Paclitaxel (Semi-Synthetic) 半合成紫杉醇 |
902 | 33069-62-4 | R0-CEP-2019-110-Rev 02 |
| US DMF 25822 (CA: A) | ||||
| GMP Certificate No.: FJ20160008 | ||||
| CDE: Y20190000514 (A) | ||||
|
Docetaxel 多西他赛 |
903 | 114977-28-5 | R0-CEP-2016-204-Rev 03 | |
|
US DMF 25295 (CA: A) DMF FIRST ADEQUATE |
||||
| GMP Certificate No.: FJ20150018 | ||||
| CDE: Y20170001931 (A) | ||||
|
Docetaxel·Trihydrate 三水多西他赛 |
904 | 148408-66-6 |
CDE: Y20180001153 DMF open part |
|
|
Other antineoplastic drug 其他抗肿瘤类 |
Imatinib Mesylate (β form） 甲磺酸伊马替尼（β晶型） |
809 | 220127-57-1 | CDE: Y20190021319 (A) |
| GMP Certificate No.: FJSC2021-011 | ||||
|
Pazopanib Hydrochloride 盐酸培唑帕尼 |
725 | 635702-64-6 | DMF open part | |
|
Bendamustine HCL Monohydrate 盐酸苯达莫司汀一水合物 |
893 | 1374784-02-7 | CDE: Y20180001674 (A) | |
| GMP Certificate No.: FJSC2021-009 | ||||
|
Pemetrexed disodium 7 hydrate 培美曲塞二钠7水合物 |
806 | 357166-29-1 | DMF open part | |
|
Pemetrexed disodium 2.5 hydrate 培美曲塞二钠2.5水合物 |
807 | 357166-30-4 | DMF open part | |
|
Azacitidine 阿扎胞苷 |
896 | 320-67-2 |
CDE: Y20210000243 (A) DMF open part |
|
| GMP Certificate No.: FJSC2023-002 | ||||
|
Apalutamide 阿帕他胺 |
899 | 956104-40-8 |
CDE: Y20220001262 DMF open part |
|
|
Relugolix 瑞卢戈利 |
719 | 737789-87-6 | DMF open part | |
|
Gemcitabine HCL 盐酸吉西他滨 |
849 | 122111-03-9 |
CDE: Y20210000720 (A) GMP Certificate No.: FJSC2024-040 |
|
|
Irinotecan HCL 盐酸伊立替康 |
869 | 136572-09-3 |
CDE: Y20220000229 (A) DMF open part |
|
|
Methotrexate 甲氨蝶呤 |
850 | 59-05-2 | DMF open part | |
|
Antiemetic 止吐剂 |
Granisetron 格拉司琼 |
714 | 109889-09-0 |
CDE: Y20230000432 DMF open part |
|
Treatment of Tuberculosis 抗结核 |
Pyrifazimine 吡法齐明 |
735 | 1353734-12-9 | DMF open part |
|
Treatment of edema 水肿治疗 |
Bumetanide 布美他尼 |
732 | 28395-03-1 | DMF open part |
|
Treatment of hypertension 高血压治疗 |
Nicardipine HCL 盐酸尼卡地平 |
/ | 54527-84-3 | DMF open part |
|
Transthyretin-related amyloid cardiomyopathy 转甲状腺素介导的淀粉样变性的心肌病 |
Tafamidis 氯苯唑酸 |
727 | 594839-88-0 | DMF open part |
|
Treatment of pancreatitis and anti-coagulation 胰腺炎治疗及抗凝血 |
Nafamostat mesylate
甲磺酸萘莫司他 |
739 | 82956-11-4 | DMF open part |
|
Treatment of thrombocytopenia 血小板减少治疗 |
Avatrombopag Meleate
马来酸阿伐曲泊帕 |
711 | 677007-74-8 |
CDE: Y20220000791 DMF open part |
|
Eltrombopag Olamine
艾曲泊帕乙醇胺 |
720 | 496775-62-3 |
CDE: Y20230000991 DMF open part |
|
|
Treatment of epilepsy 抗癫痫 |
Brivaracetam 布立西坦 |
709 | 357336-20-0 |
CDE: Y20220001065 DMF open part |
|
Anti-rheumatic agent 抗风湿 |
Baricitinib巴瑞替尼 |
721 | 1187594-09-7 |
CDE: Y20230000885 DMF open part |
|
Mucolytic agent 黏液溶解剂 |
Acetylcysteine 乙酰半胱氨酸 |
705 | 616-91-1 |
CDE: Y20210001183 (A) DMF open part |
|
Treatment of dry eye 干眼症治疗 |
Diquafosol Sodium 地夸磷索钠 |
706 | 211427-08-6 |
CDE: Y20220000228 DMF open part |
|
Lifitegrast 立他司特 |
730 | 1025967-78-5 | DMF open part | |
|
Anti-gout 抗痛风 |
Topiroxostat 托吡司特 |
713 | 577778-58-6 | PDMF open part |
|
Depigmenting Agent 祛斑剂 |
Hydroquinone 氢醌（对苯二酚） |
733 | 123-31-9 | DMF open part |
|
Phosphate binder 磷酸盐结合剂 |
Lanthanum carbonate 碳酸镧 |
724 | 6487-39-4 |
CDE: Y20230001019 DMF open part |
南方制药官方微信
南方制药官方微信